Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis

Detalles Bibliográficos
Autores principales: Graf, Tilmann, Thiele, Thomas, Klingebiel, Randolf, Greinacher, Andreas, Schäbitz, Wolf-Rüdiger, Greeve, Isabell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140563/
https://www.ncbi.nlm.nih.gov/pubmed/34023956
http://dx.doi.org/10.1007/s00415-021-10599-2
_version_ 1783696212130529280
author Graf, Tilmann
Thiele, Thomas
Klingebiel, Randolf
Greinacher, Andreas
Schäbitz, Wolf-Rüdiger
Greeve, Isabell
author_facet Graf, Tilmann
Thiele, Thomas
Klingebiel, Randolf
Greinacher, Andreas
Schäbitz, Wolf-Rüdiger
Greeve, Isabell
author_sort Graf, Tilmann
collection PubMed
description
format Online
Article
Text
id pubmed-8140563
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81405632021-05-24 Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis Graf, Tilmann Thiele, Thomas Klingebiel, Randolf Greinacher, Andreas Schäbitz, Wolf-Rüdiger Greeve, Isabell J Neurol Letter to the Editors Springer Berlin Heidelberg 2021-05-22 2021 /pmc/articles/PMC8140563/ /pubmed/34023956 http://dx.doi.org/10.1007/s00415-021-10599-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editors
Graf, Tilmann
Thiele, Thomas
Klingebiel, Randolf
Greinacher, Andreas
Schäbitz, Wolf-Rüdiger
Greeve, Isabell
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
title Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
title_full Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
title_fullStr Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
title_full_unstemmed Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
title_short Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
title_sort immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in sars-covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia vitt with cerebral sinus venous and portal vein thrombosis
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140563/
https://www.ncbi.nlm.nih.gov/pubmed/34023956
http://dx.doi.org/10.1007/s00415-021-10599-2
work_keys_str_mv AT graftilmann immediatehighdoseintravenousimmunoglobulinsfollowedbydirectthrombininhibitortreatmentiscrucialforsurvivalinsarscovid19adenoviralvectorvaccineinducedimmunethromboticthrombocytopeniavittwithcerebralsinusvenousandportalveinthrombosis
AT thielethomas immediatehighdoseintravenousimmunoglobulinsfollowedbydirectthrombininhibitortreatmentiscrucialforsurvivalinsarscovid19adenoviralvectorvaccineinducedimmunethromboticthrombocytopeniavittwithcerebralsinusvenousandportalveinthrombosis
AT klingebielrandolf immediatehighdoseintravenousimmunoglobulinsfollowedbydirectthrombininhibitortreatmentiscrucialforsurvivalinsarscovid19adenoviralvectorvaccineinducedimmunethromboticthrombocytopeniavittwithcerebralsinusvenousandportalveinthrombosis
AT greinacherandreas immediatehighdoseintravenousimmunoglobulinsfollowedbydirectthrombininhibitortreatmentiscrucialforsurvivalinsarscovid19adenoviralvectorvaccineinducedimmunethromboticthrombocytopeniavittwithcerebralsinusvenousandportalveinthrombosis
AT schabitzwolfrudiger immediatehighdoseintravenousimmunoglobulinsfollowedbydirectthrombininhibitortreatmentiscrucialforsurvivalinsarscovid19adenoviralvectorvaccineinducedimmunethromboticthrombocytopeniavittwithcerebralsinusvenousandportalveinthrombosis
AT greeveisabell immediatehighdoseintravenousimmunoglobulinsfollowedbydirectthrombininhibitortreatmentiscrucialforsurvivalinsarscovid19adenoviralvectorvaccineinducedimmunethromboticthrombocytopeniavittwithcerebralsinusvenousandportalveinthrombosis

Ejemplares similares